chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: slept the next day; headache; arm was sore; felt unwell/ felt like she had chemicals thru her whole body and felt unwell; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (slept the next day), MALAISE (felt unwell/ felt like she had chemicals thru her whole body and felt unwell), CHILLS (chills), PYREXIA (fever) and HEADACHE (headache) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, the patient experienced MALAISE (felt unwell/ felt like she had chemicals thru her whole body and felt unwell), CHILLS (chills), PYREXIA (fever) and MYALGIA (arm was sore). On 06-Apr-2021, the patient experienced SOMNOLENCE (slept the next day) and HEADACHE (headache). On 06-Apr-2021, SOMNOLENCE (slept the next day) and PYREXIA (fever) had resolved. On 07-Apr-2021, CHILLS (chills) had resolved. On 11-Apr-2021, MYALGIA (arm was sore) outcome was unknown. On 12-Apr-2021, HEADACHE (headache) had resolved. At the time of the report, MALAISE (felt unwell/ felt like she had chemicals thru her whole body and felt unwell) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported No treatment medications were reported   This case was linked to US-MODERNATX, INC.-MOD-2021-090255 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-090255:
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Back pain, Dysstasia, Hypoaesthesia
Clinical narrative: Numbness down whole left leg hip to feet; Burning down whole left leg hip to feet; Pain in left hip; Cannot stand greater than 10 minutes; Lost sense of smell; Lost sense of taste; Lower back started hurting; Immediately felt pain after "shot" in whole arm going to shoulder; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Immediately felt pain after "shot" in whole arm going to shoulder), ANOSMIA (Lost sense of smell), AGEUSIA (Lost sense of taste), BACK PAIN (Lower back started hurting) and HYPOAESTHESIA (Numbness down whole left leg hip to feet) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. unknown and unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 21-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced PAIN (Immediately felt pain after "shot" in whole arm going to shoulder). On 22-Apr-2021, the patient experienced ANOSMIA (Lost sense of smell), AGEUSIA (Lost sense of taste) and BACK PAIN (Lower back started hurting). On 24-Apr-2021, the patient experienced HYPOAESTHESIA (Numbness down whole left leg hip to feet), SCIATICA (Burning down whole left leg hip to feet), PAIN (Pain in left hip) and DYSSTASIA (Cannot stand greater than 10 minutes). At the time of the report, PAIN (Immediately felt pain after "shot" in whole arm going to shoulder), ANOSMIA (Lost sense of smell), AGEUSIA (Lost sense of taste), BACK PAIN (Lower back started hurting), HYPOAESTHESIA (Numbness down whole left leg hip to feet), SCIATICA (Burning down whole left leg hip to feet), PAIN (Pain in left hip) and DYSSTASIA (Cannot stand greater than 10 minutes) outcome was unknown.            Patient gave consent for Safety follow up,Prefers phone call. Tylenol is taken as treatment medication.   This case was linked to MOD-2021-090169 (Parent-Child Link).   See case MOD-2021-090169 for details regarding the child case.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Sciatica
Clinical narrative: Numbness down whole left leg hip to feet; Burning down whole left leg hip to feet; Pain in left hip; Cannot stand greater than 10 minutes; Lost sense of smell; Lost sense of taste; Lower back started hurting; Immediately felt pain after "shot" in whole arm going to shoulder; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Immediately felt pain after "shot" in whole arm going to shoulder), ANOSMIA (Lost sense of smell), AGEUSIA (Lost sense of taste), BACK PAIN (Lower back started hurting) and HYPOAESTHESIA (Numbness down whole left leg hip to feet) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. unknown and unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 21-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced PAIN (Immediately felt pain after "shot" in whole arm going to shoulder). On 22-Apr-2021, the patient experienced ANOSMIA (Lost sense of smell), AGEUSIA (Lost sense of taste) and BACK PAIN (Lower back started hurting). On 24-Apr-2021, the patient experienced HYPOAESTHESIA (Numbness down whole left leg hip to feet), SCIATICA (Burning down whole left leg hip to feet), PAIN (Pain in left hip) and DYSSTASIA (Cannot stand greater than 10 minutes). At the time of the report, PAIN (Immediately felt pain after "shot" in whole arm going to shoulder), ANOSMIA (Lost sense of smell), AGEUSIA (Lost sense of taste), BACK PAIN (Lower back started hurting), HYPOAESTHESIA (Numbness down whole left leg hip to feet), SCIATICA (Burning down whole left leg hip to feet), PAIN (Pain in left hip) and DYSSTASIA (Cannot stand greater than 10 minutes) outcome was unknown.            Patient gave consent for Safety follow up,Prefers phone call. Tylenol is taken as treatment medication.   This case was linked to MOD-2021-090169 (Parent-Child Link).   See case MOD-2021-090169 for details regarding the child case.
Sex: U
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Patient had change in hearing and tinnitus after first dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of TINNITUS (Patient had change in hearing and tinnitus after first dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hearing loss (Pre-existing hearing loss).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TINNITUS (Patient had change in hearing and tinnitus after first dose). At the time of the report, TINNITUS (Patient had change in hearing and tinnitus after first dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-080311 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-080311:crosslinked
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia
Clinical narrative: Lost sense of smell; Lost sense of taste; This spontaneous case was reported by a consumer and describes the occurrence of ANOSMIA (Lost sense of smell) and AGEUSIA (Lost sense of taste) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form(s). On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form(s). On 29-Mar-2021, the patient experienced ANOSMIA (Lost sense of smell) and AGEUSIA (Lost sense of taste). At the time of the report, ANOSMIA (Lost sense of smell) and AGEUSIA (Lost sense of taste) outcome was unknown.            no other medication reported treatment include Tylenol. Action taken with mRNA-1273 in response to the event was not applicable
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Rash pruritic
Clinical narrative: itchy rash on the neck, upper chest, and back; rash on the neck, upper chest, and back; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (itchy rash on the neck, upper chest, and back) and RASH (rash on the neck, upper chest, and back) in an 88-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history information provided.  Concomitant products included APIXABAN (ELIQUIS) and FINASTERIDE for an unknown indication.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH PRURITIC (itchy rash on the neck, upper chest, and back) and RASH (rash on the neck, upper chest, and back). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, RASH PRURITIC (itchy rash on the neck, upper chest, and back) and RASH (rash on the neck, upper chest, and back) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included anti-itch ointment
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Head discomfort, Mobility decreased, Muscle twitching
Clinical narrative: Can't move other than to go to the bathroom after 2nd dose; Muscle twitches after 2nd dose; Pressure in head after 2nd dose; Extremely fatigued after 2nd dose; chills after 2nd dose; body aches after 2nd dose; This spontaneous case was reported by a patient and describes the occurrence of MOBILITY DECREASED (Can't move other than to go to the bathroom after 2nd dose), MUSCLE TWITCHING (Muscle twitches after 2nd dose), HEAD DISCOMFORT (Pressure in head after 2nd dose), FATIGUE (Extremely fatigued after 2nd dose) and CHILLS (chills after 2nd dose) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041b21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 15-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MOBILITY DECREASED (Can't move other than to go to the bathroom after 2nd dose), MUSCLE TWITCHING (Muscle twitches after 2nd dose), HEAD DISCOMFORT (Pressure in head after 2nd dose), FATIGUE (Extremely fatigued after 2nd dose), CHILLS (chills after 2nd dose) and MYALGIA (body aches after 2nd dose). At the time of the report, MOBILITY DECREASED (Can't move other than to go to the bathroom after 2nd dose), MUSCLE TWITCHING (Muscle twitches after 2nd dose) and HEAD DISCOMFORT (Pressure in head after 2nd dose) outcome was unknown, FATIGUE (Extremely fatigued after 2nd dose) had not resolved and CHILLS (chills after 2nd dose) and MYALGIA (body aches after 2nd dose) had resolved.            Concomitant medication information not provided.  Treatment information not provided.  Action taken with mRNA-1273 in response to the event/s was not applicable.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Can't move other than to go to the bathroom after 2nd dose; Muscle twitches after 2nd dose; Pressure in head after 2nd dose; Extremely fatigued after 2nd dose; chills after 2nd dose; body aches after 2nd dose; This spontaneous case was reported by a patient and describes the occurrence of MOBILITY DECREASED (Can't move other than to go to the bathroom after 2nd dose), MUSCLE TWITCHING (Muscle twitches after 2nd dose), HEAD DISCOMFORT (Pressure in head after 2nd dose), FATIGUE (Extremely fatigued after 2nd dose) and CHILLS (chills after 2nd dose) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041b21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 15-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MOBILITY DECREASED (Can't move other than to go to the bathroom after 2nd dose), MUSCLE TWITCHING (Muscle twitches after 2nd dose), HEAD DISCOMFORT (Pressure in head after 2nd dose), FATIGUE (Extremely fatigued after 2nd dose), CHILLS (chills after 2nd dose) and MYALGIA (body aches after 2nd dose). At the time of the report, MOBILITY DECREASED (Can't move other than to go to the bathroom after 2nd dose), MUSCLE TWITCHING (Muscle twitches after 2nd dose) and HEAD DISCOMFORT (Pressure in head after 2nd dose) outcome was unknown, FATIGUE (Extremely fatigued after 2nd dose) had not resolved and CHILLS (chills after 2nd dose) and MYALGIA (body aches after 2nd dose) had resolved.            Concomitant medication information not provided.  Treatment information not provided.  Action taken with mRNA-1273 in response to the event/s was not applicable.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal, Headache, Incorrect dose administered, Pain in extremity
Clinical narrative: Concerned that she didn't get enough of the vaccine; Headache; Felt dizzy; Sore arm; Bruise at injection site; Started not feeling good; Injection site swelled like "a piece of bubble gum"; Bled excessively; This spontaneous case was reported by a health care professional and describes the occurrence of VACCINATION SITE HAEMORRHAGE (Bled excessively), DIZZINESS (Felt dizzy), PAIN IN EXTREMITY (Sore arm), VACCINATION SITE BRUISING (Bruise at injection site) and FEELING ABNORMAL (Started not feeling good) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cholesterol (PMH includes controlled cholesterol), Sulfonamide allergy (Sulfa drugs allergy.) and Drug allergy (Feldene allergy.).   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced VACCINATION SITE HAEMORRHAGE (Bled excessively) and VACCINATION SITE SWELLING (Injection site swelled like "a piece of bubble gum"). On 21-Apr-2021, the patient experienced DIZZINESS (Felt dizzy), PAIN IN EXTREMITY (Sore arm), VACCINATION SITE BRUISING (Bruise at injection site) and HEADACHE (Headache). 21-Apr-2021, the patient experienced FEELING ABNORMAL (Started not feeling good). On 26-Apr-2021, the patient experienced INCORRECT DOSE ADMINISTERED (Concerned that she didn't get enough of the vaccine). The patient was treated with Manual therapy (Band aid) for Vaccination site haemorrhage and Manual therapy (massage and pressure applied) for Vaccination site swelling. On 26-Apr-2021, VACCINATION SITE BRUISING (Bruise at injection site) and INCORRECT DOSE ADMINISTERED (Concerned that she didn't get enough of the vaccine) had resolved. At the time of the report, VACCINATION SITE HAEMORRHAGE (Bled excessively), DIZZINESS (Felt dizzy), PAIN IN EXTREMITY (Sore arm), FEELING ABNORMAL (Started not feeling good), HEADACHE (Headache) and VACCINATION SITE SWELLING (Injection site swelled like "a piece of bubble gum") had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provider by the reporter.  Action taken with mRNA-1273 in response to the events was not Applicable.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site bruising, Vaccination site haemorrhage, Vaccination site swelling
Clinical narrative: Concerned that she didn't get enough of the vaccine; Headache; Felt dizzy; Sore arm; Bruise at injection site; Started not feeling good; Injection site swelled like "a piece of bubble gum"; Bled excessively; This spontaneous case was reported by a health care professional and describes the occurrence of VACCINATION SITE HAEMORRHAGE (Bled excessively), DIZZINESS (Felt dizzy), PAIN IN EXTREMITY (Sore arm), VACCINATION SITE BRUISING (Bruise at injection site) and FEELING ABNORMAL (Started not feeling good) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cholesterol (PMH includes controlled cholesterol), Sulfonamide allergy (Sulfa drugs allergy.) and Drug allergy (Feldene allergy.).   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced VACCINATION SITE HAEMORRHAGE (Bled excessively) and VACCINATION SITE SWELLING (Injection site swelled like "a piece of bubble gum"). On 21-Apr-2021, the patient experienced DIZZINESS (Felt dizzy), PAIN IN EXTREMITY (Sore arm), VACCINATION SITE BRUISING (Bruise at injection site) and HEADACHE (Headache). 21-Apr-2021, the patient experienced FEELING ABNORMAL (Started not feeling good). On 26-Apr-2021, the patient experienced INCORRECT DOSE ADMINISTERED (Concerned that she didn't get enough of the vaccine). The patient was treated with Manual therapy (Band aid) for Vaccination site haemorrhage and Manual therapy (massage and pressure applied) for Vaccination site swelling. On 26-Apr-2021, VACCINATION SITE BRUISING (Bruise at injection site) and INCORRECT DOSE ADMINISTERED (Concerned that she didn't get enough of the vaccine) had resolved. At the time of the report, VACCINATION SITE HAEMORRHAGE (Bled excessively), DIZZINESS (Felt dizzy), PAIN IN EXTREMITY (Sore arm), FEELING ABNORMAL (Started not feeling good), HEADACHE (Headache) and VACCINATION SITE SWELLING (Injection site swelled like "a piece of bubble gum") had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provider by the reporter.  Action taken with mRNA-1273 in response to the events was not Applicable.
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Vision blurred
Clinical narrative: Blurred vision; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (Blurred vision) and NAUSEA (Nausea) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VISION BLURRED (Blurred vision) and NAUSEA (Nausea). At the time of the report, VISION BLURRED (Blurred vision) and NAUSEA (Nausea) outcome was unknown.            The patient received their 2nd dose and about 3-4 days later the patient developed nausea and blurred vision.  No Concomitant product use was reported. No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not applicable.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Headache. Concomitant products included PARACETAMOL (TYLENOL) for Headache, OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) for an unknown indication.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 26-Mar-2021, PAIN IN EXTREMITY (Sore arm) had resolved. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Other relevant concomitant medications included, birth control medication was reported.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-090177 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-090177:
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Chills, Dizziness, Myalgia
Clinical narrative: Lightheadedness; Feeling of losing her balance; Body aches; Extreme Chills and can not get warm; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Lightheadedness), BALANCE DISORDER (Feeling of losing her balance), MYALGIA (Body aches) and CHILLS (Extreme Chills and can not get warm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 012L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Feb-2021, the patient experienced DIZZINESS (Lightheadedness), BALANCE DISORDER (Feeling of losing her balance), MYALGIA (Body aches) and CHILLS (Extreme Chills and can not get warm). At the time of the report, DIZZINESS (Lightheadedness), BALANCE DISORDER (Feeling of losing her balance), MYALGIA (Body aches) and CHILLS (Extreme Chills and can not get warm) outcome was unknown. Not Provided
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: Received third dose; This spontaneous case was reported by a nurse and describes the occurrence of EXTRA DOSE ADMINISTERED (Received third dose) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Valley fever on 30-Jun-2021. Concurrent medical conditions included Hypertension since 20-Jan-2021, Hyperlipidemia since 20-Jan-2021, Obesity since 26-Apr-2021 and Thoracic aortic aneurysm (Ascending Thoracic Aortic Aneurysm) since 26-Apr-2021.   On 26-Apr-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Apr-2021, the patient experienced EXTRA DOSE ADMINISTERED (Received third dose). On 26-Apr-2021, EXTRA DOSE ADMINISTERED (Received third dose) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. Treatment medications were unknown.    Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Patient demographics was added Height, weight, Race, ethnicity, Historical and current  conditions was added
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Gait disturbance, Pain
Clinical narrative: dizzy; feet and hands extremely cold; obvious issue with circulation; no color in fingers or toes; couldn't sit or stand; had to lay down; aches; fever,fever shot up to 101; chills; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (couldn't sit or stand), PAIN (aches), DIZZINESS (dizzy), PERIPHERAL COLDNESS (feet and hands extremely cold) and PERIPHERAL VASCULAR DISORDER (obvious issue with circulation) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included PARACETAMOL (TYLENOL) for Headache, CLARITHROMYCIN (CLARITIN [CLARITHROMYCIN]) for an unknown indication.   On 24-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced PAIN (aches), PYREXIA (fever,fever shot up to 101) and CHILLS (chills). On 22-Apr-2021, the patient experienced GAIT DISTURBANCE (couldn't sit or stand), DIZZINESS (dizzy), PERIPHERAL COLDNESS (feet and hands extremely cold), PERIPHERAL VASCULAR DISORDER (obvious issue with circulation), PALLOR (no color in fingers or toes) and FATIGUE (had to lay down). On 23-Apr-2021, GAIT DISTURBANCE (couldn't sit or stand), PAIN (aches), DIZZINESS (dizzy), PERIPHERAL COLDNESS (feet and hands extremely cold), PERIPHERAL VASCULAR DISORDER (obvious issue with circulation), PALLOR (no color in fingers or toes), PYREXIA (fever,fever shot up to 101), CHILLS (chills) and FATIGUE (had to lay down) had resolved.            Treatment details not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-090174 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-090174:
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Pallor, Peripheral coldness, Peripheral vascular disorder, Pyrexia
Clinical narrative: dizzy; feet and hands extremely cold; obvious issue with circulation; no color in fingers or toes; couldn't sit or stand; had to lay down; aches; fever,fever shot up to 101; chills; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (couldn't sit or stand), PAIN (aches), DIZZINESS (dizzy), PERIPHERAL COLDNESS (feet and hands extremely cold) and PERIPHERAL VASCULAR DISORDER (obvious issue with circulation) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included PARACETAMOL (TYLENOL) for Headache, CLARITHROMYCIN (CLARITIN [CLARITHROMYCIN]) for an unknown indication.   On 24-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced PAIN (aches), PYREXIA (fever,fever shot up to 101) and CHILLS (chills). On 22-Apr-2021, the patient experienced GAIT DISTURBANCE (couldn't sit or stand), DIZZINESS (dizzy), PERIPHERAL COLDNESS (feet and hands extremely cold), PERIPHERAL VASCULAR DISORDER (obvious issue with circulation), PALLOR (no color in fingers or toes) and FATIGUE (had to lay down). On 23-Apr-2021, GAIT DISTURBANCE (couldn't sit or stand), PAIN (aches), DIZZINESS (dizzy), PERIPHERAL COLDNESS (feet and hands extremely cold), PERIPHERAL VASCULAR DISORDER (obvious issue with circulation), PALLOR (no color in fingers or toes), PYREXIA (fever,fever shot up to 101), CHILLS (chills) and FATIGUE (had to lay down) had resolved.            Treatment details not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-090174 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-090174:
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dysgeusia, Headache, Myalgia, Pyrexia
Clinical narrative: Rash on her left breast; Bulls eye size rash on her left armpit; Metallic taste in her mouth; Chills; Low grade fever; Very bad headache; Body ache; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (Metallic taste in her mouth), RASH (Bulls eye size rash on her left armpit), RASH (Rash on her left breast), CHILLS (Chills) and PYREXIA (Low grade fever) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045B21A. and 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     NO MEDICAL HISTORY WAS PROVIDED.  Concomitant products included METOPROLOL and LEVOTHYROXINE for an unknown indication.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced DYSGEUSIA (Metallic taste in her mouth). 22-Apr-2021, the patient experienced CHILLS (Chills), PYREXIA (Low grade fever), HEADACHE (Very bad headache) and MYALGIA (Body ache). On 24-Apr-2021, the patient experienced RASH (Bulls eye size rash on her left armpit). On 25-Apr-2021, the patient experienced RASH (Rash on her left breast). The patient was treated with CORTISONE at an unspecified dose and frequency and ZINC OXIDE at an unspecified dose and frequency. At the time of the report, DYSGEUSIA (Metallic taste in her mouth), RASH (Bulls eye size rash on her left armpit), RASH (Rash on her left breast), CHILLS (Chills), PYREXIA (Low grade fever), HEADACHE (Very bad headache) and MYALGIA (Body ache) outcome was unknown. Not Provided          The action taken with mRNA-1273 in response to the event was not applicable.    This case was linked to MOD-2021-090185.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on her left breast; Bulls eye size rash on her left armpit; Metallic taste in her mouth; Chills; Low grade fever; Very bad headache; Body ache; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (Metallic taste in her mouth), RASH (Bulls eye size rash on her left armpit), RASH (Rash on her left breast), CHILLS (Chills) and PYREXIA (Low grade fever) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045B21A. and 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     NO MEDICAL HISTORY WAS PROVIDED.  Concomitant products included METOPROLOL and LEVOTHYROXINE for an unknown indication.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced DYSGEUSIA (Metallic taste in her mouth). 22-Apr-2021, the patient experienced CHILLS (Chills), PYREXIA (Low grade fever), HEADACHE (Very bad headache) and MYALGIA (Body ache). On 24-Apr-2021, the patient experienced RASH (Bulls eye size rash on her left armpit). On 25-Apr-2021, the patient experienced RASH (Rash on her left breast). The patient was treated with CORTISONE at an unspecified dose and frequency and ZINC OXIDE at an unspecified dose and frequency. At the time of the report, DYSGEUSIA (Metallic taste in her mouth), RASH (Bulls eye size rash on her left armpit), RASH (Rash on her left breast), CHILLS (Chills), PYREXIA (Low grade fever), HEADACHE (Very bad headache) and MYALGIA (Body ache) outcome was unknown. Not Provided          The action taken with mRNA-1273 in response to the event was not applicable.    This case was linked to MOD-2021-090185.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Discomfort, Eye irritation, Headache, Myalgia
Clinical narrative: Had burning eyes; Discomfort; Bone aches; Headache; a Little of temperature , like fever ( ¨39. something C¨); Nausea; Body aches; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of EYE IRRITATION (Had burning eyes), DISCOMFORT (Discomfort), BONE PAIN (Bone aches), HEADACHE (Headache) and PYREXIA (a Little of temperature , like fever ( ¨39. something C¨)) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Stroke (veins were clogging up but did not exploit,) on 14-Feb-2020. Concomitant products included ERENUMAB (AIMOVIG [ERENUMAB]) for Stroke, IRON, BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) and CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for an unknown indication, MONTELUKAST SODIUM (SINGULAIR) for product used for unknown indication.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced EYE IRRITATION (Had burning eyes), DISCOMFORT (Discomfort), BONE PAIN (Bone aches), HEADACHE (Headache), PYREXIA (a Little of temperature , like fever ( ¨39. something C¨)), NAUSEA (Nausea) and MYALGIA (Body aches). On 01-Apr-2021, EYE IRRITATION (Had burning eyes), DISCOMFORT (Discomfort), BONE PAIN (Bone aches), HEADACHE (Headache), PYREXIA (a Little of temperature , like fever ( ¨39. something C¨)), NAUSEA (Nausea) and MYALGIA (Body aches) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication include Tylenol.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: Had burning eyes; Discomfort; Bone aches; Headache; a Little of temperature , like fever ( ¨39. something C¨); Nausea; Body aches; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of EYE IRRITATION (Had burning eyes), DISCOMFORT (Discomfort), BONE PAIN (Bone aches), HEADACHE (Headache) and PYREXIA (a Little of temperature , like fever ( ¨39. something C¨)) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Stroke (veins were clogging up but did not exploit,) on 14-Feb-2020. Concomitant products included ERENUMAB (AIMOVIG [ERENUMAB]) for Stroke, IRON, BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) and CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for an unknown indication, MONTELUKAST SODIUM (SINGULAIR) for product used for unknown indication.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced EYE IRRITATION (Had burning eyes), DISCOMFORT (Discomfort), BONE PAIN (Bone aches), HEADACHE (Headache), PYREXIA (a Little of temperature , like fever ( ¨39. something C¨)), NAUSEA (Nausea) and MYALGIA (Body aches). On 01-Apr-2021, EYE IRRITATION (Had burning eyes), DISCOMFORT (Discomfort), BONE PAIN (Bone aches), HEADACHE (Headache), PYREXIA (a Little of temperature , like fever ( ¨39. something C¨)), NAUSEA (Nausea) and MYALGIA (Body aches) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication include Tylenol.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on chest and body; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on chest and body) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032B21A and 026A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Apr-2021, the patient experienced RASH (Rash on chest and body). At the time of the report, RASH (Rash on chest and body) outcome was unknown.            Concomitant product use was not provided by the reporter.  Treatment medication use was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Non significant follow up On 03-Aug-2021: TCR received - NNI FU and denied consent for FU
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Headache
Clinical narrative: headache and burning inside the head; headache and burning inside the head; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache and burning inside the head) and BURNING SENSATION (headache and burning inside the head) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache and burning inside the head) and BURNING SENSATION (headache and burning inside the head). At the time of the report, HEADACHE (headache and burning inside the head) and BURNING SENSATION (headache and burning inside the head) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Reporter did not allow further contact
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling hot, Hyperhidrosis, Lethargy, Night sweats, Pain in extremity
Clinical narrative: night sweats; sleeping a lot; lethargy; overheated; sweating; he experienced pain in his arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (he experienced pain in his arm), NIGHT SWEATS (night sweats), SOMNOLENCE (sleeping a lot), LETHARGY (lethargy) and FEELING HOT (overheated) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, the patient experienced PAIN IN EXTREMITY (he experienced pain in his arm). On 20-Apr-2021, the patient experienced NIGHT SWEATS (night sweats), SOMNOLENCE (sleeping a lot), LETHARGY (lethargy), FEELING HOT (overheated) and HYPERHIDROSIS (sweating). At the time of the report, PAIN IN EXTREMITY (he experienced pain in his arm), NIGHT SWEATS (night sweats), LETHARGY (lethargy), FEELING HOT (overheated) and HYPERHIDROSIS (sweating) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: night sweats; sleeping a lot; lethargy; overheated; sweating; he experienced pain in his arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (he experienced pain in his arm), NIGHT SWEATS (night sweats), SOMNOLENCE (sleeping a lot), LETHARGY (lethargy) and FEELING HOT (overheated) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, the patient experienced PAIN IN EXTREMITY (he experienced pain in his arm). On 20-Apr-2021, the patient experienced NIGHT SWEATS (night sweats), SOMNOLENCE (sleeping a lot), LETHARGY (lethargy), FEELING HOT (overheated) and HYPERHIDROSIS (sweating). At the time of the report, PAIN IN EXTREMITY (he experienced pain in his arm), NIGHT SWEATS (night sweats), LETHARGY (lethargy), FEELING HOT (overheated) and HYPERHIDROSIS (sweating) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Body temperature, Chest discomfort, Chills, Dyspnoea
Clinical narrative: Tingling in her lower extremities, legs and feet; Pain in her jaw, around her molars on right side; Mild chest pressure; Feels like she has mild anxiety; Mild shortness of breath; Strong headaches; Fatigue; nausea; Body aches; Strong chills; Fever 102; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling in her lower extremities, legs and feet), PAIN IN JAW (Pain in her jaw, around her molars on right side), CHEST DISCOMFORT (Mild chest pressure), ANXIETY (Feels like she has mild anxiety) and DYSPNOEA (Mild shortness of breath) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Antiphospholipid syndrome. Concomitant products included RIVAROXABAN (XARELTO) for an unknown indication.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Apr-2021, the patient experienced PARAESTHESIA (Tingling in her lower extremities, legs and feet), PAIN IN JAW (Pain in her jaw, around her molars on right side), CHEST DISCOMFORT (Mild chest pressure), ANXIETY (Feels like she has mild anxiety), DYSPNOEA (Mild shortness of breath), HEADACHE (Strong headaches), FATIGUE (Fatigue), NAUSEA (nausea), MYALGIA (Body aches), CHILLS (Strong chills) and PYREXIA (Fever 102). At the time of the report, PARAESTHESIA (Tingling in her lower extremities, legs and feet), PAIN IN JAW (Pain in her jaw, around her molars on right side), CHEST DISCOMFORT (Mild chest pressure), ANXIETY (Feels like she has mild anxiety), DYSPNOEA (Mild shortness of breath), HEADACHE (Strong headaches), FATIGUE (Fatigue), NAUSEA (nausea), MYALGIA (Body aches), CHILLS (Strong chills) and PYREXIA (Fever 102) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Apr-2021, Body temperature: 102 (High) Fever 102.         No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Batch number updated
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Nausea, Pain in jaw
Clinical narrative: Tingling in her lower extremities, legs and feet; Pain in her jaw, around her molars on right side; Mild chest pressure; Feels like she has mild anxiety; Mild shortness of breath; Strong headaches; Fatigue; nausea; Body aches; Strong chills; Fever 102; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling in her lower extremities, legs and feet), PAIN IN JAW (Pain in her jaw, around her molars on right side), CHEST DISCOMFORT (Mild chest pressure), ANXIETY (Feels like she has mild anxiety) and DYSPNOEA (Mild shortness of breath) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Antiphospholipid syndrome. Concomitant products included RIVAROXABAN (XARELTO) for an unknown indication.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Apr-2021, the patient experienced PARAESTHESIA (Tingling in her lower extremities, legs and feet), PAIN IN JAW (Pain in her jaw, around her molars on right side), CHEST DISCOMFORT (Mild chest pressure), ANXIETY (Feels like she has mild anxiety), DYSPNOEA (Mild shortness of breath), HEADACHE (Strong headaches), FATIGUE (Fatigue), NAUSEA (nausea), MYALGIA (Body aches), CHILLS (Strong chills) and PYREXIA (Fever 102). At the time of the report, PARAESTHESIA (Tingling in her lower extremities, legs and feet), PAIN IN JAW (Pain in her jaw, around her molars on right side), CHEST DISCOMFORT (Mild chest pressure), ANXIETY (Feels like she has mild anxiety), DYSPNOEA (Mild shortness of breath), HEADACHE (Strong headaches), FATIGUE (Fatigue), NAUSEA (nausea), MYALGIA (Body aches), CHILLS (Strong chills) and PYREXIA (Fever 102) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Apr-2021, Body temperature: 102 (High) Fever 102.         No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Batch number updated